Hostname: page-component-84b7d79bbc-rnpqb Total loading time: 0 Render date: 2024-07-25T11:45:57.892Z Has data issue: false hasContentIssue false
  • English
  • Français

Biology of personality disorders

Published online by Cambridge University Press:  18 September 2015

S. Tuinier  and
W.M.A. Verhoeven
S. Tuinier
Affiliation:
Vincent van Gogh Instituut voor Psychiatrie, Stationsweg 46, 5803 AC Venray
W.M.A. Verhoeven*
Affiliation:
Vincent van Gogh Instituut voor Psychiatrie, Stationsweg 46, 5803 AC Venray
*
Vincent van Gogh Instituut voor Psychiatrie, Stationsweg 46, 5803 AC Venray
Get access Rights & Permissions [Opens in a new window]

Summary

Since the introduction of international psychiatric classification systems, systematic diagnostic methods have become available for personality disorders. Recent developments in the dimensional diagnostic approach of personality disorders have yielded relationships between this type of disorders and neurobiological processes including both monoaminergic and stress-hormonal systems. It is hypothesized that the pathogenesis of borderline personality disorders is related to an enhanced serotonergic tone in septo-hippocampal structures. Preliminary clinical data are suggestive for potential therapeutic effects of serotonin-modulating compounds in borderline personality disorders

Keywords

Dimensional diagnosingborderline personality disordersserotonin-modulating compoundsstress-hormonesDimensionele diagnostiekborderline persoonlijkheidsstoornissenserotonine-modulerende farmacostresshormonen
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 7 , Issue 4 , December 1995 , pp. 127 - 131
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literatuur

1.Frances, A. Categorical and dimensional systems of personality diagnosis: a comparison. Comp Psychiat 1982; 23: 516–27.CrossRefGoogle ScholarPubMed
2.Widiger, TA, Trull, TJ, Hurt, SW, Clardin, J, Frances, A. A multidimensional scaling of the DSM-III personality disorders. Arch gen Psychiat 1987; 44: 567–63.CrossRefGoogle ScholarPubMed
3.Zimmerman, M. Diagnosing personality disorders. A review of issues and research methods. Arch gen Psychiat 1994; 51: 225–45.CrossRefGoogle ScholarPubMed
4.Garnet, KE, Levy, KN, Mattanah, JJ, Edell, WS, McGlashan, TH. Borderline personality disorder in adolescents: ubiquitous or specific? Am J Psychiat 1994; 151: 1380–2.Google ScholarPubMed
5.Roningstam, E, Gunderson, J, Lyons, M. Changes in pathological narcissism. Am J Psychiat 1995; 152: 253–7.Google Scholar
6.Ricciardi, JN, Baer, L, Jenike, MA, Fischer, SC, Sholtz, D, Buttolph, ML. Changes in DSM-III-R Axis II diagnoses following treatment obsessive-compulsive disorder. Am J Psychiat 1992; 149: 829–31.Google ScholarPubMed
7.Vize, C, Tyrer, P. The relationship between personality and other psychiatric disorders. Curr Opin Psychiat 1994; 7: 123–8.CrossRefGoogle Scholar
8.Oldham, JM, Skodol, AE, Kellman, HD, Hyler, SE, Doidge, N, Rosnick, L, Gallaher, PE. Comorbidity of axis I and axis II disorders. Am J Psychiat 1995; 152: 571–78.Google ScholarPubMed
9.Cloninger, CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch gen Psychiat 1987; 44: 573–88.CrossRefGoogle ScholarPubMed
10.Cloninger, CR. Tridimensional Personality Questionnaire (TPQ). St. Louis: Washington University School of Medicine, Department of Psychiatry and Genetics 1987.Google Scholar
11.Eysenck, HJ, Eysenck, SBG. Personality Structure and Measurement. London: Routledge & Kegan Paul, 1969.Google Scholar
12.Millon, T. Toward a new personology. An Evolutionary Model. New York: John Wiley 1990; 99–129.Google Scholar
13.Cloninger, CR, Svrakic, DM, Przybeck, TR. A psychobiological model of temperament and character. Arch gen Psychiat 1993; 50: 975–90.CrossRefGoogle ScholarPubMed
14.Joyce, PR, Mulder, RT, Cloninger, CR. Temperament predicts clomipramine and desipramine response in major depression. J affect Disord 1994; 30: 35–46.CrossRefGoogle ScholarPubMed
15.Van Praag, HM. 5-HT-related, anxiety- and/or aggression-driven depression. Int clin Psychopharmacol 1994; 9(suppl 1): 5–6.CrossRefGoogle ScholarPubMed
16.Tuinier, S, Verhoeven, WMA. Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis. Eur Neuropsychopharmacol 1995; 5: 135–46.CrossRefGoogle ScholarPubMed
17.Verhoeven, WMA, Dosen, A, Tuinier, S, Sijben, AES. Automutilatie bij zwakzinnigen; een multidisciplinaire benadering. Acta neu-ropsychiat 1993; 5: 42–7.Google Scholar
18.Tuinier, S, Verhoeven, WMA. Pharmacological advances in mental retardation: a need for reconceptualization. Curr Opin Psychiat 1994; 7: 380–6.CrossRefGoogle Scholar
19.Tuinier, S, Verhoeven, WMA. Gedragsfarmacologie: naar een neurobiologisch substraat van persoonlijkheidsstoornissen? Tijd-schrift voor Therapie, Geneesmiddel en Onderzoek 1995; 20:10-4.Google Scholar
20.De Kloet, RE, Joëls, M, Oitzl, M, Sutanto, W. Implication of brain corticosteroid receptor diversity for the adaptation syndrome concept. In: Jasmin, G, Cantin, M eds. Neuroendocrinology of Stress. Methods Ach Exp Pathol. Basel: Karger, 1991(14): 104-32.Google Scholar
21.Kavoussi, RJ, Siever, LJ. Biologic validators of personality disorders. In: Oldham, JM ed. Personality Disorders: new Perspectives on diagnostic Validity. Washington: American Psychiatric Press, 1991; 73–87.Google Scholar
22.Hollander, E, Stein, DJ, DeCaria, CM, et al.Serotonergic Sensitivity in borderline Personality Disorder: preliminary Findings. Am J Psychiat 1994; 151: 277–80.Google ScholarPubMed
23.Kontaxakis, VP, Christodoulou, GN, Markianos, M, Stefanis, C. Pharmacotherapeutic response of DST-positive borderline patients. Eur Psychiat 1995; 10: 159–60.CrossRefGoogle ScholarPubMed
24.Barden, N, Reul, JMHM, Holsboer, F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocorti-cal system? Trends Neurosci 1995; 18: 6–11.CrossRefGoogle ScholarPubMed
25.Takore, JH, Dinan, TG. Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiat 1995; 37: 364–8.CrossRefGoogle Scholar
26.Missagh Ghadirian, A, Engelsmann, F, Dhar, V, Fillipini, D, Keller, R, Chouinard, G, Murphy, BPP. The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment. Biol Psychiat 1995; 37: 369–75.CrossRefGoogle ScholarPubMed
27.Korte, SM, De Boer, SF, De Kloet, ER, Bohus, B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psy-choneuroendocrinol 1994; 20: 385–94.CrossRefGoogle Scholar
28.Tuinier, S, Verhoeven, WMA, Van Praag, H. CSF-5-HIAA and aggression; a critical reappraisal of the clinical data. Int clin Psychopharmacol 1995; in press.Google Scholar
29.Coccaro, EF, Siever, LJ, Klar, HM, Maurer, G, Chochrane, K, Cooper, TB, Mohs, RC, Davis, KL. Serotonergic studies in patients with affective and personality disorders. Arch gen Psychiat 1989; 46: 587–99.CrossRefGoogle ScholarPubMed
30.De Kloet, RE. Brain corticosteroid receptor balance and homeo-static control. Front in Neuroendocrinol 1991; 12: 95–164.Google Scholar
31.Sapolsky, RM. Potential behavior modification of glucocorticoid damage to the hippocampus. Behav Brain Res 1993; 57: 175–182.CrossRefGoogle ScholarPubMed
32.Sapolsky, RM. Cortisol concentrations and the social significance of rank instability among wild baboons. Psychoneuroendocrinol 1992; 17:701-09.CrossRefGoogle ScholarPubMed
33.Meaney, MJ, Aitken, DH, Van Berkel, C, Bhathagar, S. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239: 766–8.CrossRefGoogle ScholarPubMed
34.Meaney, MJ, Bhatnagar, S, Diorio, J, Larocque, S, Francis, D, O'Donnell, D, Shanks, N, Sharma, S, Smythe, J, Viau, V. Molecular basis for the development of individual differences in the hypotha-lamic-pituitary-adrenal stress response. Cell mol Neurobiol 1993; 13:321-47.CrossRefGoogle ScholarPubMed
35.Levine, S. The ontogeny of the hypothalamic-pituitary-adrenal axis. The influence of maternal factors. Ann NY Acad Sci 1994; 30: 275–88.CrossRefGoogle Scholar
36.Swaab, DF, Hofman, MA. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci 1995; 18: 264–70.CrossRefGoogle ScholarPubMed
37.De Kloet, ER, Oitzl, MS, Joels, M. Functional implications of brain corticosteroid receptor diversity. Cell mol Neurobiol 1993; 13: 433–55.CrossRefGoogle ScholarPubMed
38.Griep, EN, Boersma, JW, De Kloet, ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469–74.Google ScholarPubMed